BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 19730147)

  • 1. Conservative treatment of vestibular schwannoma: a follow-up study on clinical and quality-of-life outcome.
    Godefroy WP; Kaptein AA; Vogel JJ; van der Mey AG
    Otol Neurotol; 2009 Oct; 30(7):968-74. PubMed ID: 19730147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservative management of vestibular schwannomas - second review of a prospective longitudinal study.
    Raut VV; Walsh RM; Bath AP; Bance ML; Guha A; Tator CH; Rutka JA
    Clin Otolaryngol Allied Sci; 2004 Oct; 29(5):505-14. PubMed ID: 15373864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal assessment of quality of life and audiometric test outcomes in vestibular schwannoma patients treated with gamma knife surgery.
    Park SS; Grills IS; Bojrab D; Pieper D; Kartush J; Maitz A; Martin A; Perez E; Hahn Y; Ye H; Martinez A; Chen P
    Otol Neurotol; 2011 Jun; 32(4):676-9. PubMed ID: 21436750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservative management of vestibular schwannoma--a prospective cohort study: treatment, symptoms, and quality of life.
    Breivik CN; Varughese JK; Wentzel-Larsen T; Vassbotn F; Lund-Johansen M
    Neurosurgery; 2012 May; 70(5):1072-80; discussion 1080. PubMed ID: 22067416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translabyrinthine surgery for disabling vertigo in vestibular schwannoma patients.
    Godefroy WP; Hastan D; van der Mey AG
    Clin Otolaryngol; 2007 Jun; 32(3):167-72. PubMed ID: 17550503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative management versus surgery for small vestibular schwannomas.
    Bozorg Grayeli A; Kalamarides M; Ferrary E; Bouccara D; El Gharem H; Rey A; Sterkers O
    Acta Otolaryngol; 2005 Oct; 125(10):1063-8. PubMed ID: 16298787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences to hearing during the conservative management of vestibular schwannomas.
    Walsh RM; Bath AP; Bance ML; Keller A; Rutka JA
    Laryngoscope; 2000 Feb; 110(2 Pt 1):250-5. PubMed ID: 10680925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose.
    Lasak JM; Klish D; Kryzer TC; Hearn C; Gorecki JP; Rine GP
    Otol Neurotol; 2008 Dec; 29(8):1179-86. PubMed ID: 18931646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term hearing preservation in vestibular schwannoma.
    Stangerup SE; Thomsen J; Tos M; Cayé-Thomasen P
    Otol Neurotol; 2010 Feb; 31(2):271-5. PubMed ID: 19887973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life after unilateral acoustic neuroma surgery via middle cranial fossa approach.
    Baumann I; Polligkeit J; Blumenstock G; Mauz PS; Zalaman IM; Maassen MM
    Acta Otolaryngol; 2005 Jun; 125(6):585-91. PubMed ID: 16076706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vestibular schwannoma: surgery or gamma knife radiosurgery? A prospective, nonrandomized study.
    Myrseth E; Møller P; Pedersen PH; Lund-Johansen M
    Neurosurgery; 2009 Apr; 64(4):654-61; discussion 661-3. PubMed ID: 19197222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life of patients following stages III-IV vestibular schwannoma surgery using the retrosigmoid and translabyrinthine approaches.
    Rameh C; Magnan J
    Auris Nasus Larynx; 2010 Oct; 37(5):546-52. PubMed ID: 20185256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery.
    Pollock BE; Driscoll CL; Foote RL; Link MJ; Gorman DA; Bauch CD; Mandrekar JN; Krecke KN; Johnson CH
    Neurosurgery; 2006 Jul; 59(1):77-85; discussion 77-85. PubMed ID: 16823303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vestibular schwannoma (acoustic neurinoma). Natural history and quality of life].
    Tran Ba Huy P; Kania R; Legac MS
    Bull Acad Natl Med; 2008 Dec; 192(9):1725-37; discussion 1738-40. PubMed ID: 19718978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservative management of vestibular schwannomas: third review of a 10-year prospective study.
    Hajioff D; Raut VV; Walsh RM; Bath AP; Bance ML; Guha A; Tator CH; Rutka JA
    Clin Otolaryngol; 2008 Jun; 33(3):255-9. PubMed ID: 18559034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in postoperative vestibular schwannoma patients.
    Cheng S; Naidoo Y; da Cruz M; Dexter M
    Laryngoscope; 2009 Nov; 119(11):2252-7. PubMed ID: 19753619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of untreated vestibular schwannomas. Is there a role for conservative management?
    Walsh RM; Bath AP; Bance ML; Keller A; Tator CH; Rutka JA
    Rev Laryngol Otol Rhinol (Bord); 2000; 121(1):21-6. PubMed ID: 10865479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Untreated vestibular schwannomas: vertigo is a powerful predictor for health-related quality of life.
    Myrseth E; Møller P; Wentzel-Larsen T; Goplen F; Lund-Johansen M
    Neurosurgery; 2006 Jul; 59(1):67-76; discussion 67-76. PubMed ID: 16823302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vestibular schwannoma: role of conservative management.
    Suryanarayanan R; Ramsden RT; Saeed SR; Aggarwal R; King AT; Rutherford SA; Evans DG; Gillespie JE
    J Laryngol Otol; 2010 Mar; 124(3):251-7. PubMed ID: 20003606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.